Virtually all cases of cervical cancer are caused by human papillomavirus (HPV), the most common sexually transmitted infection in the U.S., but fewer than 40 percent of adolescent girls have received the three-dose vaccine developed a decade ago. Penn State researchers are among the first to examine health care access in adolescent girls in rural and urban areas and how it affects HPV vaccination rates.
The human papillomavirus (HPV) is now responsible for more than 60 percent of the cases of head and neck cancers at Penn State Milton S. Hershey Medical Center, according to Dr. David Goldenberg, director of Head and Neck Surgery.
Commonly used disinfectants do not kill human papillomavirus (HPV) that makes possible non-sexual transmission of the virus, thus creating a need for hospital policy changes, according to researchers from Penn State College of Medicine and Brigham Young University.
Craig Meyers, distinguished professor of microbiology and immunology, is a 2013 Alumni Award recipient for the College of Life Sciences, Brigham Young University (BYU). Meyers was recently honored at BYU’s homecoming celebration.
Most women no longer need annual Pap smear screening exams for cervical cancer, but that doesn't mean they should see their primary care provider less often. That is according to new guidelines issued this week by the American College of Obstetricians and Gynecologists.
Gardasil is a vaccine, approved in 2006, to protect against strains of human papillomavirus (HPV) that have been implicated as a necessary pre-condition of cervical cancer. Since the vaccine is recommended for young females before they begin sexual activity, it creates a somewhat awkward situation for parents.
Science has sought the "cause" of cancer for decades, and in the case of cervical cancer, the cause has been found. The cervix is the opening to the womb that is situated at the upper end of the vagina. Until recently the best approach to cervical cancer was to detect it early with a Pap test performed during a gynecologic examination. While the occurrence of advanced cervical cancer has dropped through widespread use of the Pap test, there are many women in the United States and millions worldwide who do not get or have access to Pap tests. This year in the United States, about 12,000 women will be diagnosed with cervical cancer. Almost 4,000 will die of the disease, which is easily detectable and easily cured, if found early, says the new edition of The Medical Minute, a service of the Penn State Milton S. Hershey Medical Center.